Flibanserin, the only FDA-approved drug for hypoactive sexual desire disorder (HSDD) in premenopausal women, may increase sexual desire and improve sexual satisfaction for some users. Studies show a modest increase in satisfying sexual events compared to placebo.
However, side effects are common and can include nausea, dizziness, drowsiness, and low blood pressure. These typically resolve with continued use, but some women discontinue treatment due to these side effects. The medication may interact with other drugs, including alcohol and some antidepressants. It’s crucial to discuss potential interactions with your physician.
Another medication, bremelanotide, is available as a nasal spray and might offer relief for women experiencing HSDD. Its side effects frequently include nausea and flushing. Results vary considerably between individuals.
Before considering any medication for HSDD, a thorough medical evaluation is necessary to rule out underlying medical or psychological conditions that might contribute to low libido. This includes a discussion of your medical history, lifestyle factors, and current medications. Your doctor can help determine the best course of action based on your individual needs and health status, and should provide comprehensive information regarding potential risks and benefits.